GH Research (GHRS) Long-Term Investments (2021 - 2025)

GH Research (GHRS) recorded quarterly Long-Term Investments of $34.5 million in Q4 2025, down 11.31% quarter-over-quarter from $38.9 million in Q3 2025, and up 3.47% on a YoY basis from $33.3 million in Q4 2024.

GH Research (GHRS) Long-Term Investments (2021 - 2025) Analysis & Trends

GH Research's Long-Term Investments history runs 5 years deep, the most recent figure standing at $34.5 million for Q4 2025.

  • In Q4 2025, Long-Term Investments rose 3.47% year-over-year to $34.5 million; the TTM figure through Dec 2025 stood at $34.5 million (up 3.47% YoY), while the FY2025 annual figure was $34.5 million, up 3.47% from the prior year.
  • Long-Term Investments was $34.5 million for Q4 2025 at GH Research, down from $38.9 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $122.1 million in Q4 2021 to a low of $33.3 million in Q4 2024.
  • Historically, Long-Term Investments has averaged $58.8 million across 5 years, with a median of $54.7 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Long-Term Investments sank 45.54% in 2024, then climbed 3.47% in 2025.
  • A 5-year view of Long-Term Investments shows it stood at $122.1 million in 2021, then declined by 29.78% to $85.7 million in 2022, then dropped by 28.68% to $61.1 million in 2023, then slumped by 45.54% to $33.3 million in 2024, then advanced by 3.47% to $34.5 million in 2025.
  • The last three Long-Term Investments figures came in at $34.5 million (Q4 2025), $38.9 million (Q3 2025), and $37.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 5.17 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 5.75 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 GH Research 9.73 Bn 9.63 Bn - 34.46 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 34.46 Mn
Sep 30, 2025 38.85 Mn
Jun 30, 2025 37.66 Mn
Mar 31, 2025 33.84 Mn
Dec 31, 2024 33.30 Mn
Sep 30, 2024 43.81 Mn
Jun 30, 2024 53.17 Mn
Mar 31, 2024 56.13 Mn
Dec 31, 2023 61.14 Mn
Sep 30, 2023 67.45 Mn
Jun 30, 2023 72.70 Mn
Mar 31, 2023 83.32 Mn
Dec 31, 2022 85.72 Mn
Dec 31, 2021 122.08 Mn